Based on 8 analysts giving stock ratings to MacroGenics Inc in the past month.
In the current month, MGNX has received 3 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. MGNX average Analyst price target in the last month is 8.000.
Based on analysts' estimates, MGNX EPS is projected to reach -0.425 in FY2026Q4, following reported EPS of -0.315 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.31, while MacroGenics IncMGNX's earnings per share (EPS) for the previous quarter was USD 0.31. EPS for the next quarter is expected at USD -0.42.